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Background: In 2010, the World Health Organization shifted its malaria guidelines from recommending the empiric
treatment of all febrile children to treating only those with laboratory-confirmed malaria. This study evaluated the
frequency and predictors of malaria over-treatment among febrile malaria-negative children in Kenya.
Methods: Between 2012 and 2013, 1,362 children presenting consecutively with temperature ≥37.5°C to Kisii and
Homa Bay hospitals were enrolled in a cross-sectional study evaluating causes of fever. Children were screened for
malaria using smear microscopy and rapid diagnostic tests and managed according to standard of care at the
hospitals. The frequency of anti-malarial prescriptions among children with laboratory-confirmed malaria negative
children (malaria over-treatment) was determined; and clinical and demographic correlates of overtreatment evaluated
using logistic regression. Because of differences in malaria endemicity, analyses were stratified and compared by site.
Results: Among 1,362 children enrolled, 46 (7%) of 685 children in Kisii, and 310 (45.8%) of 677 in Homa Bay had
laboratory-confirmed malaria; p < 0.001. Among malaria-negative children; 210 (57.2%) in Homa Bay and 45 (7.0%) in
Kisii received anti-malarials; p < 0.001. Predictors of over-treatment in Homa Bay included≥ one integrated management
of childhood illness (IMCI) danger sign (aOR = 8.47; 95% CI: 4.81-14.89), fever lasting ≥ seven days (aOR = 4.94; 95%
CI: 1.90-12.86), and fever ≥39°C (aOR = 3.07; 95% CI: 1.58-5.96). In Kisii, only fever ≥39°C predicted over-treatment
(aOR = 2.13; 95% CI: 1.02-4.45).
Conclusions: Malaria over-treatment was common, particularly in Homa Bay, where the prevalence of malaria
was extremely high. Severe illness and high or prolonged fever were associated with overtreatment. Overtreatment
may result in failure to treat other serious causes of fever, drug resistance, and unnecessarily treatment costs.
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Malaria is a leading cause of morbidity and mortality
among children in sub-Saharan Africa. The most well
recognized sign of malaria infection is fever, which ac-
counts for over 30-50% of all paediatric hospital visits in
sub-Saharan Africa [1]. Historically, international guide-
lines recommended presumptive treatment of malaria in
febrile children in endemic areas, as diagnostic tools* Correspondence: fonchiri@gmail.com
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malaria-attributable mortality that would occur if treat-
ment was delayed was high [2]. Following considerable
declines in malarial transmission in many parts of
Africa, including in highly endemic areas [3-5], the in-
creased recognition of the importance of life-threatening
non-malaria fevers [6-8] and the wide availability of
cheap and highly sensitive rapid diagnostic tests
(RDTs), the World Health Organization released new
malaria treatment guidelines in 2010 that recommend
limiting treatment to laboratory-confirmed malaria [9].
While many countries, including Kenya, have adopted
these guidelines with subsequent improvements in. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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proportion of febrile patients still continue to be
treated for malaria despite negative laboratory test
(over-treatment) [10-12].
Malaria overtreatment may result in the failure to
treat other serious causes of fever, particularly blood
stream infections [7,8]. Mortality among children
treated for malaria is over two-fold higher in malaria-
negative children than in children with laboratory-
confirmed malaria, often as a result of untreated
bacterial infections [7,8,13]. Additionally, malaria over-
treatment can lead to the emergence of drug resistance,
unnecessary adverse drug effects, increased treatment
costs, and reduced quality of care [14,15]. Because of
the serious potential consequences of malaria over-
treatment, it is important to understand why some chil-
dren are inappropriately treated with anti-malarials.
This information will inform fever management and
may improve understanding of guideline adherence in
low-resource settings.
Methods
Study design, sites, and population
This was a cross-sectional study nested within an
ongoing surveillance study of febrile illnesses among
children at Kisii Provincial Hospital and Homa Bay
District Hospital, both in Western Kenya. These hospitals
are situated in areas with historically different malaria en-
demicity: Kisii is hypo-endemic with annual entomologic
inoculation rate (EIR) of <1.5 infectious bites per person
per year. Homa Bay historically has been holo-endemic
with EIR of ≥300 infectious bites per person per year
[16,17], although malaria prevalence declined by over 50%
from 2003 to 2007 [4,5] but then reversed to levels
observed in 2003 [18]. Children ages six months to 15
years presenting with axillary temperature ≥37.5°C at the
out-patient departments (OPD) were approached con-
secutively for enrolment and almost all were enrolled in
OPD (98%). A minority of study children (<2%) were
admitted to the wards directly from OPD and enrolled
from the inpatient ward. Eligible children included
those whose accompanying parents/guardians con-
sented to HIV counseling and study participation of
their children. Because this study was nested within a
large surveillance study of febrile illnesses, data from all
children enrolled at the time (April 2012 – November
2013) of analysis presented in this paper were used. The
study was approved by the Ethical Review Committees
of both the University of Washington and the Kenya
Medical Research Institute.
Study and hospital clinical staff
Clinical staff at the study sites consists of clinical officers
and registered nurses with three years of medicaltraining and licensed to independently diagnose and
treat diseases, including ordering and interpreting la-
boratory tests. There are very few medical doctors avail-
able for direct clinical care. The new malaria “test and
treat” policy was adopted by the Kenyan Ministry of
Health in 2011, and subsequently health workers re-
ceived in-service malaria case-management training [11].
However, structured monitoring and supervision of mal-
aria treatment and treatment practices are not routinely
available. Study clinicians/nurses worked together with
hospitals’ clinical staff and assisted with the diagnosis
and treatment of patients regardless of their eventual
study participation statues.Training
Study staff was trained on enrolment criteria, consent,
clinical and laboratory procedures, use of integrated
management of childhood illness (IMCI) syndromic
management algorithms, and assessment of danger
signs. Because the parent study was a cross-sectional
study aimed at understanding bacterial etiologies of
fever, the study protocol did not stipulate standardized
treatment protocols for malaria and clinicians managed
sick children according to the standard of care practices
at the hospitals.Data collection
During screening and enrolment, study clinicians and
registered nurses systematically captured comprehensive
information regarding sociodemographics, anthropomet-
ric characteristics, past medical history and care-seeking
behaviour, and current clinical and laboratory data using
standardized case report forms. Clinicians also recorded
diagnoses and prescribed treatments. Children with any
of the IMCI danger signs (unable to drink or breastfeed,
convulsions, continuous vomiting, lethargy, and/or
unconsciousness) were classified as having severe febrile
illness [19]. All screened and enrolled children were
tested for malaria using both smear microscopy and
Paracheck Pf® RDTs (Orchid Biomedical Services, India).
At each hospital, the same hospital microscopists pre-
pared and read malaria slides. Malaria results were avail-
able to clinicians within 20–30 minutes of testing. These
microscopists received no additional training before the
study. Because causes of fever such as bacteraemia are
associated with HIV [20] and malaria [21], children were
tested for HIV using rapid antibody testing (Abbott
Determine™ rapid test kit and confirmed using Uni-
Gold™) or PCR if child ≤18 months. Finally, blood was
cultured using BACTEC 9050 blood culture system, and
pathogens were identified using a Microscan Walk away
system. Results of the analyses of bacteremia data are
presented elsewhere [22].
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Laboratory-confirmed malaria was defined as a positive
smear microscopy and/or RDT test. Malaria over-
treatment was defined as a negative smear and RDT re-
sult that was treated with anti-malarials.
Statistical analysis
Demographic, clinical and laboratory characteristics
were compared between study sites using Chi-square
or Fisher’s exact tests for categorical variables and two
sample t-tests or Wilcoxon rank sum tests for continu-
ous variables.
The proportion of children laboratory-confirmed
negative malaria but were treated with anti-malarials
was estimated and compared between sites using Chi-
square test. The association between malaria over-
treatment (primary outcome) and patients’ clinical and
demographic characteristics that had been selected a
priori following a thorough literature review was first
examined in a bivariate logistic regression. These
included malnutrition, mother, and child’s HIV status,
presence of IMCI danger signs, fever of ≥ seven days,
having previously sought care, pre-treatment with anti-
malarial prior to hospitalization. To identify independ-
ent correlates of malaria over-treatment, all of the
following a priori selected confounders were included
simultaneously in a multivariate logistic model: child’s
age, sex, whether the child was enrolled from out- or
in-patient departments, primary caregiver’s level of
education and income. The latter two variables were
used as surrogates for family socioeconomic status.
Because the sites had marked differences in malaria
endemicities that might impact clinician suspicion,
analyses were stratified and compared by site. All
analyses were done using Stata statistical software (ver-
sion 13.1, Stata Corp, College Station, TX, USA).
Strengthening the reporting of observational studies in
epidemiology (STROBE) guidelines were followed in
reporting this study [23].
Results
Demographic, medical history and clinical characteristics
Between April 2012 and November 2013, 1,362 febrile
children were enrolled into the parent study; 685 in Kisii
and 677 in Homa Bay. Figure 1 summarizes screening,
enrolment, clinical treatment of malaria, and laboratory
testing for malaria. Baseline demographic and clinical in-
formation of the enrolled children are shown in Table 1.
Compared to children from Kisii, children from Homa
Bay were younger, more likely to be female, more likely
to be acutely malnourished (underweight), not to have
received all age-appropriate vaccines, and sicker at pres-
entation as defined by the presence of IMCI danger sign
(s) (52.6% vs 16.1%; p < 0.001). Children in Homa Baywere more likely to have HIV-infected mothers (19.5%
vs 3.3%; p < 0.001) or to be HIV infected themselves
(4.5% vs 1.3%; p < 0.001) than those from Kisii. However,
children from Homa Bay were less likely to be wasted,
and to have previously sought health care elsewhere for
their current illness than children from Kisii (23.0% vs
33.9%; p = 0.001).
Malaria diagnoses
Among febrile children, 26% had laboratory-confirmed
malaria infection; 45.8% in Homa Bay and 6.7% in Kisii;
prevalence ratio = 6.82; 95% CI: 5.22-8.90. Among
laboratory-confirmed malaria cases (n = 356), 96.1%
were positive by both RDT and smear, 10 (2.8%) were
positive by RDT alone and 4 (1.1%) were positive by
smear alone. In Kisii, the prevalence of bacteraemia
among children with and without malaria was 4.1%
(26/639) and 2.2% (1/46), respectively, p = 0.524. The
prevalence of bacteremia among children with and
without malaria was 4.5% (45/1006) and 2.0% (7/35),
respectively; p = 0.034.
Malaria treatment and correlates of malaria over-treatment
All children with laboratory-confirmed malaria (n = 356)
were treated with anti-malarials regardless of their ini-
tial provisional presumptive diagnosis. Most (82.3%
received artemisinin combination therapy (ACT), while
17.7% received quinine. Children treated with quinine
were more likely than those treated with ACT to have
danger sign(s) present 76.2% (48/63) vs. 47.1% (138/
293); p < 0.001. Among children with laboratory-
confirmed negative malaria (639 in Kisii and 367 in
Homa Bay), the proportion of those treated with anti-
malarials was significantly higher in Homa Bay as
compared to Kisii (57.2% vs. 7.0% p < 0.001). Overall,
among those over-treated, children treated with quin-
ine were more likely than those treated with ACT to
have danger sign(s) present 76.2% (48/63) vs. 47.1%
(138/293); p < 0.001.
Because the site characteristics and patients’ demo-
graphic and clinical characteristics were so distinct, ana-
lyses were stratified and compared by site. In Kisii, odds
of malaria over-treatment were significantly higher for
children with high-grade fever (odds ratio (OR) = 2.14;
95% CI: 1.21-4.37), those who had taken anti-malarials
in the week preceding hospitalization (OR = 2.14; 95%
CI: 1.03-4.44) and those whose mothers were HIV-
infected (OR = 3.26; 95% CI: 1.11-9.58) in bivariate ana-
lysis (Table 2). In multivariate analysis, only high-grade
fever was associated with over-treatment (aOR = 2.13;
95% CI: 1.02-4.45).
In Homa Bay, signs and symptoms of severe sickness
were associated with over-treatment. The unadjusted
odds of malaria over-treatment for children with both
Figure 1 Flow chart showing enrolment of children by study site, laboratory, clinical diagnosis of malaria and treatment.
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nificantly higher for children with high-grade fever
(OR = 2.07; 95% CI: 1.27-3.39), a history of fever lasting
a week or more (OR = 2.94; 95% CI: 1.41-6.14), and at
least one IMCI danger signs present (OR = 5.78; 95%
CI: 3.66-9.14) (Table 3). However, the odds of over-
treatment were lower for children who reported seek-
ing care prior to current hospital visit (OR = 0.49; 95%
CI: 0.30-0.79) and lower for children who had reported
having taken antibiotics within the last one week
(OR = 0.42; 95% CI: 0.18-0.98). These associations
persisted and strengthened in multivariate logistic
regression analyses adjusting simultaneously for a
priori selected confounders that included sex, age of
the children, whether children were enrolled from in-
patient or outpatient department, and primary care-
givers’ education and income. In multivariate analysis,
malaria over-treatment in Homa Bay was significantly
associated with high-grade fever ≥39°C (aOR = 3.07;
95% CI: 1.58-5.96), a history of fever lasting a week
or more (aOR = 4.98; 95% CI: 1.90-12.80), and pres-
ence of at least one IMCI danger sign (aOR = 8.47;
95% CI: 4.81-14.89). Notably, there was no significant
association of malaria over-treatment with HIV-
infection.
Antibiotic treatment
More children with negative laboratory malaria diagnos-
tic tests were treated with both anti-malarials andantibiotics in Homa Bay than in Kisii (45.8 vs 6.3%;
p < 0.001). In Homa Bay, children more likely to be
treated with both anti-malarials and antibiotics in-
cluded those who presented with a history of fever
lasting a week or more (OR = 2.38; 95% CI: 1.09-5.20)
or manifested an IMCI danger sign(s) (OR = 4.58; 95%
CI: 2.78-7.22). In Kisii, although children presenting
with high-grade fever of ≥39°C but without malaria were
more likely to receive both anti-malarials and antibiotics
(OR = 2.26; 95% CI: 1.22-4.16), the presence of IMCI dan-
ger signs was not predictive of dual treatment (OR = 1.21;
95% CI: 0.55-2.69).
Discussion
Current malaria treatment guidelines recommend
restricting anti-malarials to confirmed malaria cases
only. This study assessed anti-malarial prescribing
practices at two regional rural hospitals in western
Kenya and found that malaria endemicity appears to be
a major driver of clinicians’ adherence to malaria la-
boratory test results.
Clinicians correctly adhered to positive test results
and prescribed all malaria-positive children with anti-
malarials at both sites. However, more than half (57.2%)
of febrile children with laboratory-confirmed negative
malaria in a high malaria transmission area were pre-
scribed anti-malarials compared to only 7.0% in a low
malaria transmission area. In Kisii, the only strong pre-
dictor of malaria over-treatment was a fever of >39°C.
Table 1 Demographic and clinical characteristics of children by site
Study site
Variable All sites Kisii Homa Bay
n % n (%) n (%) p
n = 1,362 n = 685 n = 677
Demographics
Child’s sex: Female 652 (44.7) 306 (44.7) 346 (51.1) 0.017
Age in years (Mean ± SD) (Median) 35.4 ± 34 (34) 3.1 ± 2.1 (2.9) 2.8 ± 1.6 (2.8) 0.012
Age (years) <0.001
≤2 yr 501 (36.8) 256 (37.4) 245 (36.2)
3-4 yr 721 (53.0) 335 (49.0) 386 (57.1)
≥5 yr 138 (10.1) 93 (13.6) 45 (6.7)
Uses water from unimproved sourcesi 171 (12.6) 26 (3.8) 145 (21.4) <0.001
Primary caregiver’s characteristics
Education <0.001
College/university 159 (11.7) 101 (14.8) 58 (8.6)
Secondary 425 (31.2) 273 (39.9) 152 (22.5)
At most primary 777 (57.1) 310 (45.3) 467 (69.0)
Monthly income <0.001
≤$50 550 (40.4) 189 (27.6) 361 (53.3)
$50-100 495 (36.4) 275 (40.2) 220 (32.5)
>$100 316 (23.2) 220 (32.2) 96 (14.2)
Children’s clinical presentations
Malnutrition
MUAC < 12.5 40 (2.9) 15 (2.2) 25 (3.7) 0.087
Wasting (WHZ < −2)ii 193 (15.9) 115 (19.5) 78 (12.4) 0.001
Stunted (HAZ < −2)ii 181 (14.5) 83 (13.6) 98 (15.4) 0.272
Underweight (WAZ < −2)iii 127 (10.2) 52 (8.5) 75 (11.8) 0.044
Temperature (°C) <0.001
37.5-37.9 205 (15.1) 138 (20.1) 67 (9.9)
38.0-38.9 626 (46.0) 308 (45.0) 318 (47.0)
39.0-39.9 441 (32.4) 202 (29.5) 239 (35.3)
> = 40.0 90 (6.6) 37 (5.4) 53 (7.8)
High grade fever (>39°C) 468 (34.4) 206 (30.1) 262 (38.7) 0.001
≥IMCI danger sign(s) presentiv 466 (34.2) 110 (16.1) 356 (52.6) <0.001
Unable to drink/breastfeed 198 14 184
Vomits everything 271 62 209
Convulsions 81 30 51
Lethargic/unconscious 113 43 70
Past clinical history
Has had fever lasting ≥7 days 263 (38.4) 79 (11.8) <0.001
Sought healthcare elsewhere 388 (28.5) 232 (33.9) 156 (23.0) <0.001
Taken anti-malarials last 7 days 192 (14.1) 86 (12.6) 106 (15.7) 0.1000
Taken antibiotics last 7 days 84 (6.2) 52 (7.6) 32 (4.7) 0.024
Not received all age-appropriate vaccines 324 (23.8) 11 (11.8) 243 (35.9%) <0.001
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Table 1 Demographic and clinical characteristics of children by site (Continued)
Laboratory results
Mother HIV -infectedv 151 (11.4) 22 (3.3) 129 (19.5) <0.001
Child HIV-infectedvi 39 (2.9) 9 (1.3) 30 (4.5) 0.001
Malaria (smear or RDT) 356 (26.1) 46 (6.7) 310 (45.8) <0.001
Bacteraemia 52 (3.8) 27 (3.9) 25 (3.7) 0.811
iUnpiped water, unprotected boreholes, wells and springs, water from vendors.
iiValues outside plausible range for 95 children from Kisii and 50 from Homa Bay.
iiiValues outside plausible range for 74 children from Kisii and 42 from Homa Bay.
ivUnable to feed/drink, vomits everything, convulsion, unconscious, stiff neck.
vMother’s HIV status unknown for 25 children from Kisii and 15 from Homa bay.
viHIV status uknown for 15 children from Kisii and 3 from Homa Bay.
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fever >39°C, longer duration of fever, IMCI danger
signs) were the strongest predictors of over-treatment
with anti-malarials. In high malaria prevalence areas,
clinicians may have over-treated sick children because
they did not trust negative test results, and/or feared
missing possible malaria cases, with potentially fatal
consequences [24]. The finding that overtreatment is
more common in an area of high malaria transmission
is consistent with what might be expected: when
prevalence of any disease is relatively high, a clinician’s
suspicion of the disease prior to testing is also high to
avoid missing causes of disease that are common in a
given area.
The higher proportion of children with danger signs
in Homa Bay may, in part, reflect limited healthcare
exposure, delayed access to, or poor engagement with,
the health care system and inappropriate home treat-
ment of children with fever. Additionally, significantlyTable 2 Univariate and multivariate analysis of correlates of m
Over-treated
No (n = 594) Ye
Potential correlates n (%) n
Malnutrition
MUAC < 12.5 13 (2.2) 1
Wasting 107 (20.8) 5
Stunted 73 (13.7) 3
Underweight 45 (8.4) 2
Mother HIV-infected 17 (3.0) 4
Child HIV-infected 7 (1.2) 2
Any IMCI danger sign? 90 (15.2) 8
High grade fever (>39°C) 166 (27.9) 21
Fever for 7 or more days 232 (39.1) 19
Sought care elsewhere 195 (32.8) 14
Taken anti-malarial last 7 days 70 (11.8) 10
Taken antibiotics last 7 days 47 (7.9) 2
†Data insufficient to include this variable in multivariate model only two of the child
caregivers’ education and household income.fewer children in Homa Bay (the high malaria risk
area) had received all age-appropriate vaccines and
children in Homa Bay were also significantly more
likely to be HIV-infected or exposed. Because study
procedures, inclusion criteria, and training of study cli-
nicians were uniform across study sites, it is unlikely
that the higher proportion of very sick children in
Homa Bay was due to systematic selection bias or dif-
ferential misclassification.
This study found that children exhibiting signs of
severe disease were more likely to be treated for both
malaria and for presumptive blood stream infection.
More than 80% of the children at both sites were
presumptively prescribed antibiotics. This suggests
that in the absence of point-of-care diagnostics for
other causes of fever, clinicians are reluctant to miss
the opportunity to avert potential morbidity and mor-
tality and will presumptively treat children, even
when guidelines suggest otherwise. Malaria-negativealaria over-treatment in Kisii
Crude Adjusted§














ren over-diagnosed in Kisii were HIV+. §Adjusted for child’s age, sex, and
Table 3 Univariate and multivariate analysis of correlates of malaria over-treatment in Homa Bay
Over-treated Crude Adjusted§
Variable No (n = 157) Yes (n = 210) cOR (95% CI) aOR (95% CI)
Potential correlates n (%) n (%)
Malnutrition
MUAC < 12.5 4 (2.5) 10 (4.8) 1.91(0.60-6.21) 1.73(0.37-8.05)
Wasting 17 (11.4) 26 (13.6) 1.22(0.64-2.35) 0.67(0.25-1.77)
Stunted 19 (12.5) 33 (17.1) 1.44(0.78-2.68) 1.24(0.53-2.89)
Underweight 14 (9.2) 27 (14.0) 1.60(0.81-3.18) 0.93(0.30-2.89)
Mother HIV-infected 30 (19.2) 45 (22.0) 1.18(0.70-2.00) 1.19(0.59-2.50)
Child HIV-infected 6 (3.9) 15 (7.1) 1.90(0.72-5.01) 1.36(0.35-5.27)
Any IMCI danger sign? 41 (26.1) 141 (67.1) 5.78(3.66-9.14) 8.47(4.81-14.89)
High grade fever (>39°C) 30 (19.1) 69 (32.9) 2.07(1.27-3.39) 3.07(1.58-5.96)
Fever for 7 or more days 10 (6.4) 35 (16.7) 2.94(1.41-6.14) 4.94(1.90-12.86)
Sought care elsewhere 48 (30.6) 37 (17.6) 0.49(0.30-0.79) 0.32(0.18-0.63)
Taken anti-malarial last 7 days 26 (16.6) 50 (23.8) 1.57(0.93-2.67) 1.95(0.95-4.00)
Taken antibiotics last 7 days 15 (9.6) 9 (4.3) 0.42(0.18-.98) 0.17(0.05-0.55)
§Adjusted for child’s age, sex, and caregivers’ education and household income.
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compared to children with positive results (93.3 vs.
58.2%, p < 0.001), suggesting that negative malaria test
may have led clinicians to consider and treat alterna-
tive causes of fever.
The finding of significant malaria over-treatment,
particularly in very sick children in endemic areas, is
consistent with a recent Cochrane review of the effect
of RDTs on the prescription of anti-malarials in Africa
[24]. This review reported that underlying malaria
prevalence influences clinicians’ prescribing adherence
to malaria test results. Findings from this study have
important practical implications for regular refresher
in-service trainings on importance of parasitological-
supported malaria treatment, and structured supervi-
sion of clinicians to increase their adherence to “test
and treat” policy as well as their confidence in malaria
test results. Given the concern of missing possible mal-
aria infections, training should reiterate findings from
multiple trials which have shown that although RDTs
may miss some uncomplicated malaria infections,
these are mainly low-density and self-limiting infec-
tions, which rarely develop into severe malaria [25].
The finding that very sick-looking children were
treated with anti-malarials despite negative laboratory
tests suggests the need to educate clinicians that with-
holding anti-malarials from febrile malaria-negative
patients is clinically safe, even in endemic areas
[24-27]. Because malaria tests, particularly RDTs, may
be the only diagnostic tools routinely available in rural
areas in Kenya, it is necessary to train, support, and
supervise clinicians on the use of test result as basisfor prescribing anti-malarials, and that a negative test
should prompt an assessment and treatment of the
true causes of fever.
While this study had several strengths, notably the
inclusion of data from two sites in Kenya with widely
differing underlying malaria endemicity, there were
also some weaknesses. Malaria over-treatment was
only evaluated in relation to patients’ demographic
and their clinical symptoms. Other factors such as
clinicians’ level of training, number of clinical staff
and patient load, patients’ expectations, diagnostic la-
boratory capacity, and regular supervision and public
health promotional activities also likely affect clini-
cians’ malaria diagnosis and treatment decisions.
Lastly, although the inclusion of only children with
fever ≥37.5°C was intended to enhance the clinical
yield of microbiologic investigations, this may limit
the generalizability.Conclusions
Febrile patients, particularly those with signs of more
severe illness in areas of high malaria transmission, con-
tinue to be treated with anti-malarials despite negative
laboratory tests, against current WHO “test-treat” policy.
This may result in missed opportunities to accurately
diagnose and treat alternative causes of fever. There is
need for the strengthened training in fever case manage-
ment, supervision, monitoring and evaluation of malaria
treatment practices by clinicians in order to ensure ad-
herence to malaria test results, particularly in areas of
high malaria endemicity.
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